Luca Guardabassi , DVM, PhD
Professor of Clinical Microbiology, Director of the One Health Center for Zoonoses and Tropical Veterinary Medicine
Dr. Luca Guardabassi is a clinical bacteriologist with a longstanding track record on antimicrobial resistance and veterinary antimicrobial therapy. Following graduation from the Faculty of Veterinary Medicine at Pisa University in 1994, he was awarded his PhD in Veterinary Microbiology at the Royal Veterinary and Agricultural University in Denmark in 2000. He became associate professor at the University of Copenhagen in 2004 and progressed to full professor in 2012. For 20 years he has conducted research on origin, evolution, population structure and epidemiology of resistant bacteria of clinical interest. His recent research focuses on identification of new antimicrobial helper drug targets and leads to revive older antibiotics towards which bacteria have developed resistance. This research activity continues at Ross University School of Veterinary Medicine, where he was appointed as Professor of Clinical Microbiology in November 2015.
DVM Pisa University, Italy
PHD Royal Veterinary and Agricultural University, Denmark
Origin and evolution of antimicrobial resistance genes in clinical bacteria, molecular epidemiology of resistant bacteria and resistance determinants, antimicrobial drug discovery, development of new diagnostic tests for early detection and typing of veterinary and zoonotic pathogens.
Chair of the European Society of Clinical Microbiology and Infectious
Diseases (ESCMID) Study Group for Veterinary Microbiology (ESGVM).
Founder member of the EUCAST Veterinary Subcommittee on Antimicrobial Susceptibility Testing (VetCAST).
Advisor for the Clinical Laboratory Standards Institute (CLSI).
Subcommittee on Veterinary Antimicrobial Susceptibility Testing (VAST).
External Advisory Board Member for Infect-ERA.
A full list of publications is available on:
European Training Network “Training and Research Aimed at Novel Antibacterial Solutions in Animals and People“ (TRAIN-ASAP).
University of Copenhagen research center for Control of Antibiotic Resistance (UC-Care).
Improved antimicrobial activity of existing antibiotics (Zoetis grant).